Assessing tuberculosis control priorities in high-burden settings: a modelling approach
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In the context of WHO's End TB strategy, there is a need to focus future control efforts on those interventions and innovations that would be most effective in accelerating declines in tuberculosis burden. Using a modelling approach to link the tuberculosis care cascade to transmission, we aimed to identify which improvements in the cascade would yield the greatest effect on incidence and mortality. METHODS: We engaged with national tuberculosis programmes in three country settings (India, Kenya, and Moldova) as illustrative examples of settings with a large private sector (India), a high HIV burden (Kenya), and a high burden of multidrug resistance (Moldova). We collated WHO country burden estimates, routine surveillance data, and tuberculosis prevalence surveys from 2011 (for India) and 2016 (for Kenya). Linking the tuberculosis care cascade to tuberculosis transmission using a mathematical model with Bayesian melding in each setting, we examined which cascade shortfalls would have the greatest effect on incidence and mortality, and how the cascade could be used to monitor future control efforts. FINDINGS: Modelling suggests that combined measures to strengthen the care cascade could reduce cumulative tuberculosis incidence by 38% (95% Bayesian credible intervals 27-43) in India, 31% (25-41) in Kenya, and 27% (17-41) in Moldova between 2018 and 2035. For both incidence and mortality, modelling suggests that the most important cascade losses are the proportion of patients visiting the private health-care sector in India, missed diagnosis in health-care settings in Kenya, and drug sensitivity testing in Moldova. In all settings, the most influential delay is the interval before a patient's first presentation for care. In future interventions, the proportion of individuals with tuberculosis who are on high-quality treatment could offer a more robust monitoring tool than routine notifications of tuberculosis. INTERPRETATION: Linked to transmission, the care cascade can be valuable, not only for improving patient outcomes but also in identifying and monitoring programmatic priorities to reduce tuberculosis incidence and mortality. FUNDING: US Agency for International Development, Stop TB Partnership, UK Medical Research Council, and Department for International Development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60570-0 · Cited by 1,117
Tiemersma, E. W., van der Werf, M. J., Borgdorff, M. W., Williams, B. G., & Nagelkerke, N. J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017601 · Cited by 583
The South African tuberculosis care cascade: Estimated losses and methodological challenges
Naidoo, P., Theron, G., Rangaka, M. X., Chihota, V. N., Vaughan, L., Brey, Z. O., & Pillay, Y. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix335 · Cited by 238
Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya
Enos, M., Sitienei, J., Ong’ang’o, J., Mungai, B., Kamene, M., Wambugu, J., Kipruto, H., Manduku, V., Mburu, J., Nyaboke, D., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209098 · Cited by 127
Self-citation
Cited by
Hogan, A. B., Jewell, B. L., Sherrard-Smith, E., Vesga, J. F., Watson, O. J., Whittaker, C., Hamlet, A., Smith, J. A., Winskill, P., Verity, R., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30288-6 · Cited by 900
Self-citationBuilding a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Self-citationThe potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
Cilloni, L., Fu, H., Vesga, J. F., Dowdy, D., Pretorius, C., Ahmedov, S., Nair, S. A., Mosneaga, A., Masini, E., Sahu, S., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100603 · Cited by 339
Self-citationThe Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal
Kendall, E. A., Shrestha, S., & Dowdy, D. W. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2394pp · Cited by 185
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01379-x · Cited by 87
Self-citation
Metadata
- Authors
- Vesga, J. F., Hallett, T. B., Reid, M. J. A., Sachdeva, K. S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E., Masini, E., Omale, N., Onyango, E., Owiti, P., Karanja, M., Kiplimo, R., Alexandru, S., Vilc, V., Crudu, V., Bivol, S., Celan, C., & Arinaminpathy, N.
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 7
- Issue
- 5
- Pages
- e585-e595
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W2923504095
- Cited by
- 82
- References
- 4
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing tuberculosis control priorities in high-burden settings: a modelling approach. https://app.cochat.ai/papers/10.1016/s2214-109x(19)30037-3
- The paper
- Vesga, J. F., Hallett, T. B., Reid, M. J. A., Sachdeva, K. S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E., Masini, E., Omale, N., Onyango, E., Owiti, P., Karanja, M., Kiplimo, R., Alexandru, S., Vilc, V., Crudu, V., . . . Arinaminpathy, N. (2019). Assessing tuberculosis control priorities in high-burden settings: a modelling approach. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(19)30037-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.